Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 7/2005

01-07-2005 | Article

Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation

Authors: H. Viskari, J. Ludvigsson, R. Uibo, L. Salur, D. Marciulionyte, R. Hermann, G. Soltesz, M. Füchtenbusch, A.-G. Ziegler, A. Kondrashova, A. Romanov, B. Kaplan, Z. Laron, P. Koskela, T. Vesikari, H. Huhtala, M. Knip, H. Hyöty

Published in: Diabetologia | Issue 7/2005

Login to get access

Abstract

Aims/hypothesis

We have previously observed an inverse correlation between the incidence of type 1 diabetes and enterovirus infections in the background population. The aim of this study was to analyse whether maternal enterovirus antibody status, which reflects both the frequency of enterovirus infections and the protection conferred by the mother on the offspring, also correlates with the incidence of type 1 diabetes.

Methods

Maternal enterovirus antibodies were analysed from serum samples taken from pregnant women between 1983 and 2001 in Finland and Sweden using enzyme immunoassay and neutralisation assays. Comparable samples were also taken between 1999 and 2001 in countries with a lower incidence of diabetes (Estonia, Germany, Hungary, Israel, Lithuania, Russia).

Results

A clear decrease was observed in maternal enterovirus antibody levels over the past 20 years (p<0.0001). The frequency of enterovirus antibodies was higher in countries with a low or intermediate incidence of type 1 diabetes compared with high-incidence countries (p<0.0001).

Conclusions/interpretation

These findings are in line with our previous observations supporting the hypothesis that a low frequency of enterovirus infection in the background population increases the susceptibility of young children to the diabetogenic effect of enteroviruses.
Literature
1.
Podar T, Solntsev A, Karvonen M et al (2001) Increasing incidence of childhood-onset type I diabetes in 3 Baltic countries and Finland 1983–1998. Diabetologia 44(Suppl 3):B17–B20PubMed
2.
Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361PubMed
3.
Kondrashova A, Reunanen A, Romanov A et al (2005) A sixfold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 37:67–72CrossRef
4.
Virtanen SM, Aro A (1994) Dietary factors in the aetiology of diabetes. Ann Med 26:469–478PubMed
5.
6.
Viskari HR, Koskela P, Lönnrot M et al (2000) Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 23:414–416PubMed
7.
Viskari H, Ludvigsson J, Uibo R et al (2004) Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 72:610–617CrossRefPubMed
8.
Lönnrot M, Knip M, Marciulionyte D et al (1999) Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care 22:2086–2088PubMed
9.
Pallansch MA, Roos RP (2001) Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams &Wilkins, Philadelphia, pp 723–775
10.
Morens D, Pallansh M (1995) Epidemiology. In: Rotbart H (ed) Human enterovirus infections. ASM, Washington DC, pp 3–23
11.
Alexander LM, Heaven A, Tennant A, Morris R (1992) Symptomatology of children in contact with sea water contaminated with sewage. J Epidemiol Community Health 46:340–344PubMed
12.
van Olphen M, Kapsenberg JG, van de Baan E, Kroon WA (1984) Removal of enteric viruses from surface water at eight waterworks in The Netherlands. Appl Environ Microbiol 47:927–932PubMed
13.
Ozere RL, Faulkner R, Van Rooyen CE (1961) Enteroviruses in sewage and epidemic poliomyelitis in eastern Canada. Can Med Assoc J 85:1419–1424PubMed
14.
Hovi T, Stenvik M, Rosenlew M (1996) Relative abundance of enterovirus serotypes in sewage differs from that in patients: clinical and epidemiological implications. Epidemiol Infect 116:91–97PubMed
15.
Grew N, Gohd RS, Arguedas J, Kato JI (1970) Enteroviruses in rural families and their domestic animals. Am J Epidemiol 91:518–526PubMed
16.
Kadoi K, Suzuki H, Nishio O (2001) Isolation of coxsackievirus B5 from pigs. New Microbiol 24:217–222PubMed
17.
Waldman EA, Moreira RC, Saez SG et al (1996) Human enterovirus infection in stray dogs. Some aspects of interest to public health. Rev Inst Med Trop Sao Paulo 38:157–161PubMed
18.
Zinkernagel RM (2001) Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 345:1331–1335CrossRefPubMed
19.
20.
Roivainen M, Alfthan G, Jousilahti P, Kimpimäki M, Hovi T, Tuomilehto J (1998) Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 98:2534–2537PubMed
21.
Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA (1999) Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37:1288–1293PubMed
22.
Sadeharju K, Lönnrot M, Kimpimäki T et al (2001) Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia 44:818–823CrossRefPubMed
23.
Kurikka S, Olander RM, Eskola J, Käyhty H (1996) Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr Infect Dis J 15:530–535CrossRefPubMed
24.
Roivainen M, Knip M, Hyöty H et al (1998) Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 56:74–78CrossRefPubMed
25.
Green A, Patterson CC (2001) Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia 44(Suppl 3):B3–B8CrossRefPubMed
26.
Altman DG (1991) Non-parametric test for ordered groups. In: Altman DG (ed) Practical statistics for medical research. Chapman and Hall, London, pp 215–217
27.
Altman D, Altman DG, Bryant T, Gardner M, Gardner MJ, Machin D (2000) Statistics with confidence, 2nd edn. BMJ Books, London
28.
Staines A, Bodansky HJ, McKinney PA et al (1997) Small area variation in the incidence of childhood insulin-dependent diabetes mellitus in Yorkshire, UK: links with overcrowding and population density. Int J Epidemiol 26:1307–1313CrossRefPubMed
29.
Parslow RC, McKinney PA, Law GR, Staines A, Williams R, Bodansky HJ (1997) Incidence of childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking water: an ecological analysis. Diabetologia 40:550–556CrossRefPubMed
30.
Schober E, Rami B, Waldhoer T (2003) Small area variation in childhood diabetes mellitus in Austria: links to population density, 1989 to 1999. J Clin Epidemiol 56:269–273CrossRefPubMed
31.
Patterson CC, Carson DJ, Hadden DR (1996) Epidemiology of childhood IDDM in Northern Ireland 1989–1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 39:1063–1069PubMed
32.
Parslow RC, McKinney PA, Law GR, Bodansky HJ (2001) Population mixing and childhood diabetes. Int J Epidemiol 30:533–538; discussion 538–539CrossRefPubMed
33.
Karvonen M, Rusanen J, Sundberg M et al (1997) Regional differences in the incidence of insulin-dependent diabetes mellitus among children in Finland from 1987 to 1991. Childhood Diabetes in Finland (DiMe) Study Group. Ann Med 29:297–304PubMed
34.
Rytkönen M, Moltchanova E, Ranta J, Taskinen O, Tuomilehto J, Karvonen M (2003) The incidence of type 1 diabetes among children in Finland—rural–urban difference. Health Place 9:315–325CrossRefPubMed
35.
Kaila B, Taback SP (2001) The effect of day care exposure on the risk of developing type 1 diabetes: a meta-analysis of case-control studies. Diabetes Care 24:1353–1358PubMed
36.
Pundziute-Lyckå A, Urbonaite B, Dahlquist G (2000) Infections and risk of type I (insulin-dependent) diabetes mellitus in Lithuanian children. Diabetologia 43:1229–1234CrossRefPubMed
37.
Blom L, Nystrom L, Dahlquist G (1991) The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 34:176–181CrossRefPubMed
38.
Gibbon C, Smith T, Egger P, Betts P, Phillips D (1997) Early infection and subsequent insulin dependent diabetes. Arch Dis Child 77:384–385PubMed
39.
Dahlquist GG, Patterson C, Soltesz G (1999) Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698–1702PubMed
40.
EURODIAB Substudy 2 Study Group (2000) Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. Diabetologia 43:47–53
41.
Juhela S, Hyöty H, Roivainen M, Härkonen T, Putto-Laurila A, Simell O, Ilonen J (2000) T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 49:1308–1313PubMed
42.
Bruserud O, Jervell J, Thorsby E (1985) HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426CrossRefPubMed
43.
D’Alessio DJ (1992) A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed
44.
Sadeharju K, Knip M, Hiltunen M, Åkerblom HK, Hyöty H (2003) The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 46:1100–1105CrossRefPubMed
45.
Rønningen KS, Keiding N, Green A (2001) Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44(Suppl 3):B51–B59PubMed
46.
Dahlquist G, Mustonen L (2000) Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. Acta Paediatr 89:1231–1237CrossRefPubMed
Metadata
Title
Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation
Authors
H. Viskari
J. Ludvigsson
R. Uibo
L. Salur
D. Marciulionyte
R. Hermann
G. Soltesz
M. Füchtenbusch
A.-G. Ziegler
A. Kondrashova
A. Romanov
B. Kaplan
Z. Laron
P. Koskela
T. Vesikari
H. Huhtala
M. Knip
H. Hyöty
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1780-9

Other articles of this Issue 7/2005

Diabetologia 7/2005 Go to the issue

Article

Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction

Letter

Reply to comments on: McAuley KA, Hopkins CM, Smith KJ, McLay RT, Williams SM, Taylor RW, Mann JI (2005) Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 48:8–16

Article

Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B

Article

Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes

EASD

EASD News Section July 2005

Letter Comment

To: McAuley KA, Hopkins CM, Smith KJ, McLay RT, Williams SM, Taylor RW, Mann JI (2005) Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 48:8–16
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits